Wemplat Injection
Marketer
Wembrace Biopharma Pvt. Ltd.
Salt Composition
Cisplatin (10mg)
Overview Wemplat Injection
Oncaspar injection is a prescription medication indicated for the management of ovarian, cervical, and testicular cancers. Its mechanism of action involves inhibiting or retarding the proliferation of cancerous cells. Administration is intravenous, performed exclusively by a qualified healthcare professional. Dosage and frequency are determined by your physician, based on your specific condition and may be adjusted. Strict adherence to your doctor's prescribed regimen is crucial; improper use or overdose can lead to severe adverse effects. While therapeutic benefits may not be immediately apparent (several weeks or months may elapse), discontinuation should only occur under your doctor's direction. Common side effects include injection site reactions (pain, swelling, inflammation), nausea, and emesis. Ototoxicity (hearing impairment or damage) is a potential, serious adverse event; pre- and ongoing hearing assessments may be implemented. This medication can cause myelosuppression (reduced blood cell counts), increasing infection risk. Regular blood tests are essential to monitor blood cell levels and assess cardiac, hepatic, and renal function. Prior to commencing treatment, disclose any history of renal disease, as the medication can impact kidney function. Significant drug interactions are possible; inform your healthcare provider about all medications currently being taken. The use of Oncaspar is contraindicated during pregnancy and lactation. Male infertility is a potential consequence; pre-treatment consultation regarding sperm cryopreservation is recommended.
Uses of Wemplat Injection
Cancers of the ovaries, cervix, and testes.
Major Benefits of Wemplat Injection:
This medication will be administered by your healthcare provider. Self-medication is strongly discouraged.
Common Side effects of Wemplat Injection:
- Injection site reactions (pain, swelling, redness)
- Increased risk of infection
- Ear disorder
- Vomiting
- Nausea
- Decreased blood cells (red cells, white cells, and platelets)
- Renal impairment
- Peripheral neuropathy (tingling and numbness of feet and hand)
- Kidney damage
- Hearing loss
- Ringing in ear
How to use Wemplat Injection:
This medication will be administered by your physician or registered nurse; self-medication is strictly prohibited.
How Wemplat Injection works:
Oncolytic Wemplat injection targets cancerous cells, disrupting their DNA and RNA to halt proliferation and growth.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside Wemplat Injection may pose unknown risks. Seek medical advice before combining them.
PregnancyCONSULT YOUR DOCTOR
Administering Wemplat Injection during pregnancy is contraindicated due to established risk to the fetus. In exceptional, life-threatening circumstances, a physician might prescribe it if the potential benefits outweigh the known hazards. Physician consultation is essential.
Breast feedingUNSAFE
Breastfeeding mothers should not use Wemplat Injection. Evidence indicates potential infant toxicity from this medication.
DrivingUNSAFE
Administering Wemplat Injection may induce adverse reactions that impair driving ability. These reactions can include drowsiness and/or nausea, potentially affecting safe operation of a vehicle.
KidneyCAUTION
For individuals with impaired kidney function, Wemplat Injection requires careful administration. Dosage modification of Wemplat Injection might be necessary. Physician consultation is advised. Wemplat Injection is contraindicated in patients exhibiting severe kidney disease.
LiverSAFE IF PRESCRIBED
Wemplat Injection appears to pose minimal risk for individuals with hepatic impairment. Existing evidence indicates that dose modification for Wemplat Injection is likely unnecessary in this population. Physician consultation is advised.
What if you forget to take Wemplat Injection :
Should you forget a Wemplat Injection dose, seek your physician's advice.
Facts to Know About Wemplat Injection
| Label | Value |
|---|---|
| Chemical Type | Platinum Equivalents |
| Developing Habits | No. |
| Type of Therapy | Cancer Medications |
| Action Class | Platinum-based anticancer agents |
3,018 People bought this recently